A systematic review of regulatory approved drugs and pharmacological interventions for erectile dysfunction.

A T Rajasekhar; Sheikh Shafiq Un-Nabi; Senthilraja Kaliyamoorthy; D Anusha; Nagalakshmi S

doi:10.1093/jpp/rgag013

February 6, 2026

A systematic review of regulatory approved drugs and pharmacological interventions for erectile dysfunction.

View at Publisher

Ask AI

Bookmark

Share

Key Points

This review aims to summarize available medications for erectile dysfunction and identify gaps for future research.
Systematic review of regulatory approved drugs for erectile dysfunction
Evaluation of existing pharmacological interventions
Analysis focused on pde5 inhibitors and their effectiveness
PDE5 inhibitors are highlighted as key treatments for erectile dysfunction
Identified needs for more research to enhance treatment effectiveness
Emphasis on improving overall quality of life for men with erectile dysfunction

Implication

Systematic review evaluates pde5 inhibitors for erectile dysfunction, suggesting improvements for men's treatment quality.

Abstract

In summary, this review helps doctors and researchers by providing clear information about PDE5 inhibitor drugs for ED and pointing out areas where more research can improve treatment and quality of life for men with this condition.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rajasekhar et al. (2026) studied this question.

synapsesocial.com/papers/69a3d856ec16d51705d2f267 https://doi.org/10.1093/jpp/rgag013

View at Publisher

Ask AI

Bookmark

Share

A systematic review of regulatory approved drugs and pharmacological interventions for erectile dysfunction.

Key Points

Implication

Abstract

Discussion

Cite This Study

A systematic review of regulatory approved drugs and pharmacological interventions for erectile dysfunction.

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading